comparemela.com
Home
Live Updates
Hemostemix Inc.: Hemostemix Announces $2,750,000 Convertible Debenture : comparemela.com
Hemostemix Inc.: Hemostemix Announces $2,750,000 Convertible Debenture
Calgary, Alberta--(Newsfile Corp. - March 2, 2022) - Hemostemix Inc. (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VFO) ("Hemostemix" or the "Company") is pleased to announce that it has signed a binding term sheet
Related Keywords
Canada ,
Canadian ,
Thomas Smeenk ,
Venture Exchange The ,
Common Shares Of The Company Debenture ,
Regulation Service Provider ,
Common Shares Of The Company ,
World Economic Forum Technology Pioneer Award ,
Hemostemix Inc ,
Alberta Newsfile Corp ,
Venture Exchange ,
Board Of Directors The Company ,
Each Debenture Unit ,
Common Shares ,
Common Share ,
Market Price ,
Conversion Price ,
Each Debenture Warrant ,
Debenture Units ,
Debenture Warrants ,
Term Sheet ,
Debenture Offering ,
Minority Security Holders ,
Special Transactions ,
Business Corporations Act ,
Ischemic Cardiomyopathy ,
Dilated Cardiomyopathy ,
Stem Cell Treatment ,
Regulating Stem Cells ,
Vitro Techniques ,
Neural Lineage ,
Automated Cell ,
Looking Information ,
Hemostemix ,
Nnounces ,
Convertible ,
Debenture ,
comparemela.com © 2020. All Rights Reserved.